{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T08:57:41Z","timestamp":1742806661042,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Cukurova University, Scientific Research Projects Unit","award":["TTU-2019-12009"],"award-info":[{"award-number":["TTU-2019-12009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-022-02567-0","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T07:42:39Z","timestamp":1667893359000},"page":"1701-1710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In Vitro efficacy of cyclosporine a and various antiseptics and antiviral drugs on adenovirus genotype 8, a common cause of epidemic keratoconjunctivitis"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2916-0932","authenticated-orcid":false,"given":"Aynura Sariyeva","family":"Aydamirov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Inan","family":"Harbiyeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokhan","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fugen","family":"Yarkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meltem","family":"Yagmur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"2567_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1556\/EuJMI.4.2014.1.2","volume":"4","author":"B Ghebremedhin","year":"2014","unstructured":"Ghebremedhin B (2014) Human adenovirus: viral pathogen with increasing importance. Eur J Microbiol Immunol 4:26\u201333. https:\/\/doi.org\/10.1556\/EuJMI.4.2014.1.2","journal-title":"Eur J Microbiol Immunol"},{"key":"2567_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3238\/arztebl.2011.0475","volume":"108","author":"B Meyer-Rusenberg","year":"2011","unstructured":"Meyer-Rusenberg B, Loderstadt U, Richard G, Kauffers PM, Gesser C (2011) Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment. Dtsch Arztebl Int 108:475\u2013480. https:\/\/doi.org\/10.3238\/arztebl.2011.0475","journal-title":"Dtsch Arztebl Int"},{"key":"2567_CR3","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/infdis\/167.6.1307","volume":"167","author":"JA Jernigan","year":"1993","unstructured":"Jernigan JA, Lowry BS, Hayden FG, Kyger SA, Conmay BP, Gr\u00f6schel DH et al (1993) Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis 167:1307\u20131313. https:\/\/doi.org\/10.1093\/infdis\/167.6.1307","journal-title":"J Infect Dis"},{"key":"2567_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1128\/JCM.43.2.726-732.2005","volume":"43","author":"T Ariga","year":"2005","unstructured":"Ariga T, Shimada Y, Shiratori K, Ohgami K, Yamazaki S, Tagawa Y et al (2005) Five new genome types of adenovirus type 37 caused epidemic keratoconjunctivitis in Sapporo, Japan, for more than 10 years. J Clin Microbiol 43:726\u2013732. https:\/\/doi.org\/10.1128\/JCM.43.2.726-732.2005","journal-title":"J Clin Microbiol"},{"key":"2567_CR5","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1099\/jmm.0.044172-0","volume":"61","author":"AK Adhikary","year":"2012","unstructured":"Adhikary AK, Ushijima H, Fujimoto T (2012) Human adenovirus type 8 genome typing. J Med Microbiol 61:1491\u20131503. https:\/\/doi.org\/10.1099\/jmm.0.044172-0","journal-title":"J Med Microbiol"},{"key":"2567_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jcv.2014.10.015","volume":"61","author":"AU Adhikary","year":"2014","unstructured":"Adhikary AU, Banik U (2014) Human adenovirus type 8: the major agent of epidemic keratoconjunctivitis (EKC). J Clin Virol 61:477\u2013486. https:\/\/doi.org\/10.1016\/j.jcv.2014.10.015","journal-title":"J Clin Virol"},{"key":"2567_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/AAC.31.2.337","volume":"31","author":"M Baba","year":"1987","unstructured":"Baba M, Mori S, Shigeta S, De Clerq E (1987) Selective inhibitory effect of (S)-9-(3-Hydroxy-2-Phosphonylmethoxypropyl) adenine and 2\u2019-NorCyclic GMP on adenovirus replication In Vitro. Antimicrob Agents Chemother 31:337\u2013339. https:\/\/doi.org\/10.1128\/AAC.31.2.337","journal-title":"Antimicrob Agents Chemother"},{"key":"2567_CR8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1001\/archopht.119.10.1487","volume":"119","author":"J Hillenkamp","year":"2001","unstructured":"Hillenkamp J, Reinhard T, Ross RS et al (2001) Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Arch Ophthalmol 119:1487\u20131491. https:\/\/doi.org\/10.1001\/archopht.119.10.1487","journal-title":"Arch Ophthalmol"},{"key":"2567_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1128\/CMR.12.1.147","volume":"12","author":"G McDonnell","year":"1999","unstructured":"McDonnell G, Russell AD (1999) Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev 12:147\u2013179. https:\/\/doi.org\/10.1128\/CMR.12.1.147","journal-title":"Clin Microbiol Rev"},{"key":"2567_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/jcp.25.1.76","volume":"25","author":"A Bailey","year":"1972","unstructured":"Bailey A, Longson M (1972) Virucidal activity of chlorhexidine on strains of Herpesvirus hominis, poliovirus, and adenovirus. J Clin Pathol 25:76\u201378. https:\/\/doi.org\/10.1136\/jcp.25.1.76","journal-title":"J Clin Pathol"},{"key":"2567_CR11","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/jac\/dki057","volume":"55","author":"PR Kinchington","year":"2005","unstructured":"Kinchington PR, Romanowski EG, Jerold Gordon Y (2005) Prospects for adenovirus antivirals. J Antimicrob Chemother 55:424\u2013429. https:\/\/doi.org\/10.1093\/jac\/dki057","journal-title":"J Antimicrob Chemother"},{"key":"2567_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00003226-199409000-00011","volume":"13","author":"MD Trousdale","year":"1994","unstructured":"Trousdale MD, Goldschmidt PL, N\u00f3brega R (1994) Activity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyes. Cornea 13:435\u2013439. https:\/\/doi.org\/10.1097\/00003226-199409000-00011","journal-title":"Cornea"},{"key":"2567_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1590\/s0004-27492011000600007","volume":"74","author":"ST Yabiku","year":"2011","unstructured":"Yabiku ST, Yabiku MM, Bottos KM et al (2011) Ganciclovir 0.15% ophthalmic gel in the treatment of adenoviral keratoconjunctivitis. Arq Bras Oftalmol 74:417\u2013421. https:\/\/doi.org\/10.1590\/s0004-27492011000600007","journal-title":"Arq Bras Oftalmol"},{"key":"2567_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1055\/s-2006-926633","volume":"223","author":"N Monnerat","year":"2006","unstructured":"Monnerat N, Bossart W, Thiel MA (2006) Povidone-iodine for treatment of adenoviral conjunctivitis: an in vitro study. Klin Monbl Augenheilkd 223:349\u2013352. https:\/\/doi.org\/10.1055\/s-2006-926633","journal-title":"Klin Monbl Augenheilkd"},{"key":"2567_CR15","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/IDR.S162669","volume":"11","author":"DI Chigbu","year":"2018","unstructured":"Chigbu DI, Labib BA (2018) Pathogenesis and management of adenoviral keratoconjunctivitis. Infect Drug Resist 11:981\u2013993. https:\/\/doi.org\/10.2147\/IDR.S162669","journal-title":"Infect Drug Resist"},{"key":"2567_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000246027","volume":"195","author":"R Kawana","year":"1997","unstructured":"Kawana R, Kitamura T, Nakagomi O et al (1997) Inactivation of human viruses by povidone-iodine in comparison with other antiseptics. Dermatology 195:29\u201335. https:\/\/doi.org\/10.1159\/000246027","journal-title":"Dermatology"},{"key":"2567_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1743-422X-6-124","volume":"6","author":"N Sriwilaijaroen","year":"2009","unstructured":"Sriwilaijaroen N, Wilairat P, Hiramatsu H et al (2009) Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities. Virol J 6:124. https:\/\/doi.org\/10.1186\/1743-422X-6-124","journal-title":"Virol J"},{"key":"2567_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1743-422X-6-124","volume":"45","author":"Z Kunt","year":"2002","unstructured":"Kunt Z, Yagmur M, Kandemir H et al (2002) In Vitro efficacy of chlorhexidine and a riboflavin\/UVA combination on fungal agents of keratitis. Curr Eye Res 45:7\u201311. https:\/\/doi.org\/10.1186\/1743-422X-6-124","journal-title":"Curr Eye Res"},{"key":"2567_CR19","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1136\/bjo.82.8.919","volume":"82","author":"MR Rahman","year":"1998","unstructured":"Rahman MR, Johnson GJ, Husain R, Howlader SA, Minassian DC (1998) Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol 82:919\u2013925. https:\/\/doi.org\/10.1136\/bjo.82.8.919","journal-title":"Br J Ophthalmol"},{"key":"2567_CR20","first-page":"664","volume":"11","author":"N Geffen","year":"2009","unstructured":"Geffen N, Norman G, Kheradiya NS, Assia EI (2009) Chlorhexidine gluconate 0,002% as adjunct to primary tratment for corneal bacterial ulcers. Isr Med Assoc J 11:664\u2013668","journal-title":"Isr Med Assoc J"},{"key":"2567_CR21","doi-asserted-by":"publisher","first-page":"e71815","DOI":"10.1371\/journal.pone.0071815","volume":"8","author":"Z Shen","year":"2013","unstructured":"Shen Z, He H, Wu Y, Li J (2013) Cyclosporin a inhibits rotavirus replication and restores interferon-beta signaling pathway in vitro and in vivo. Plos One 8:e71815. https:\/\/doi.org\/10.1371\/journal.pone.0071815","journal-title":"Plos One"},{"key":"2567_CR22","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/eye.2017.4","volume":"31","author":"L Asena","year":"2017","unstructured":"Asena L, S\u0131ngarOzdemir E, Burcu A et al (2017) Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis. Eye 31:781\u2013787. https:\/\/doi.org\/10.1038\/eye.2017.4","journal-title":"Eye"},{"key":"2567_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cytogfr.2014.07.015","volume":"25","author":"F Lin","year":"2014","unstructured":"Lin F, Young HA (2014) Interferons: success in anti-viral immunotherapy. Cytokine Growth Factor Rev 25:369\u2013376. https:\/\/doi.org\/10.1016\/j.cytogfr.2014.07.015","journal-title":"Cytokine Growth Factor Rev"},{"key":"2567_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/OPTH.S55284","volume":"8","author":"J Huang","year":"2014","unstructured":"Huang J, Kadonosono K, Uchio E (2014) Antiadenoviral effects of ganciclovir in types inducing keratoconjunctivitis by quantitative polymerase chain reaction methods. Clin Ophthalmol 8:315\u2013320. https:\/\/doi.org\/10.2147\/OPTH.S55284","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"2567_CR25","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3341\/kjo.2013.27.3.199","volume":"27","author":"E Uchio","year":"2013","unstructured":"Uchio E, Inoue H, Kadonosono K (2013) Anti-adenoviral effects of human cationic antimicrobial protein-18\/LL-37, an antimicrobial peptide, by quantitative polymerase chain reaction. Korean J Ophthalmol 27(3):199\u2013203. https:\/\/doi.org\/10.3341\/kjo.2013.27.3.199","journal-title":"Korean J Ophthalmol"},{"issue":"3","key":"2567_CR26","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3390\/v7031409","volume":"7","author":"K Toth","year":"2015","unstructured":"Toth K, Ying B, Tollefson AE et al (2015) Valganciclovir inhibits human adenovirus replication and pathology in permissive immunosuppressed female and male Syrian hamsters. Viruses 7(3):1409\u20131428. https:\/\/doi.org\/10.3390\/v7031409","journal-title":"Viruses"},{"issue":"1","key":"2567_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/135965350901400110","volume":"14","author":"F Morfin","year":"2009","unstructured":"Morfin F, Dupuis-Girod S, Frobert E et al (2009) Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone. Antivir Ther 14(1):55\u201361","journal-title":"Antivir Ther"},{"key":"2567_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.antiviral.2014.05.010","volume":"108","author":"J Sanchez-Cespedes","year":"2014","unstructured":"Sanchez-Cespedes J, Moyer CL, Whitby LR, Boger DL, Nemerow GR (2014) Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative. Antiviral Res 108:65\u201373. https:\/\/doi.org\/10.1016\/j.antiviral.2014.05.010","journal-title":"Antiviral Res"},{"key":"2567_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0166-3542(95)00962-0","volume":"31","author":"CB De Olviera","year":"1996","unstructured":"De Olviera CB, Stevenson D, LaBree L et al (1996) Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res 31:165\u2013172. https:\/\/doi.org\/10.1016\/0166-3542(95)00962-0","journal-title":"Antiviral Res"},{"key":"2567_CR30","first-page":"4135","volume":"35","author":"YJ Gordon","year":"1994","unstructured":"Gordon YJ, Romanowski EG, Araullo-Cruz T (1994) Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Invest Ophthalmol Vis Sci 35:4135\u20134143","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2567_CR31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1128\/jcm.26.5.1026-1028.1988","volume":"26","author":"G Woods","year":"1988","unstructured":"Woods G, Young A (1988) Use of A-549 cells in a clinical virology laboratory. J Clin Microbiol 26:1026\u20131028. https:\/\/doi.org\/10.1128\/jcm.26.5.1026-1028.1988","journal-title":"J Clin Microbiol"},{"key":"2567_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1574-6968.1993.tb06510.x","volume":"113","author":"S Lipson","year":"1993","unstructured":"Lipson S, Poshni IA, Ashley RL, Grady LJ, Ciamician Z, Teichberg S (1993) Presumptive identification of common adenovirus serotypes by the development of differential cytopathic effects in the human lung carcinoma (A549) cell culture. FEMS Microbiol Lett 113:175\u2013182. https:\/\/doi.org\/10.1111\/j.1574-6968.1993.tb06510.x","journal-title":"FEMS Microbiol Lett"},{"key":"2567_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.17925\/USOR.2012.05.02.100","volume":"5","author":"J Affedt","year":"2012","unstructured":"Affedt J, Rathod NG, Fernandez KB et al (2012) Ganciclovir in the treatment of ophthalmic viral infections\u2014case reports. US Ophthalmic Rev 5:100\u2013104","journal-title":"US Ophthalmic Rev"},{"key":"2567_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/15569527.2014.888077","volume":"34","author":"ZO Tunay","year":"2015","unstructured":"Tunay ZO, Ozdemir O, Petricli IS (2015) Povidone iodine in the treatment of adenoviral conjunctivitis in infants. Cutan Ocul Toxicol 34:12\u201315. https:\/\/doi.org\/10.3109\/15569527.2014.888077","journal-title":"Cutan Ocul Toxicol"},{"key":"2567_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0195-6701(98)90077-9","volume":"38","author":"A Wood","year":"1998","unstructured":"Wood A, Payne D (1998) The action of three antiseptics\/disinfectants against enveloped and non-enveloped viruses. J Hosp Infect 38:283\u2013295. https:\/\/doi.org\/10.1016\/s0195-6701(98)90077-9","journal-title":"J Hosp Infect"},{"key":"2567_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1017\/s0022172400064433","volume":"97","author":"V Springthorpe","year":"1986","unstructured":"Springthorpe V, Grenier J, Lloyd-Evans N, Sattar SA (1986) Chemical disinfection of human rotaviruses: efficacy of commercially-available products in suspension tests. J Hyg 97:139\u2013161. https:\/\/doi.org\/10.1017\/s0022172400064433","journal-title":"J Hyg"},{"key":"2567_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/BF01321118","volume":"122","author":"A Vahlne","year":"1992","unstructured":"Vahlne A, Larsson PA, Horal P et al (1992) Inhibition of herpes simplex virus production in vitro by cyclosporin A. Arch Virol 122:61\u201375. https:\/\/doi.org\/10.1007\/BF01321118","journal-title":"Arch Virol"},{"key":"2567_CR38","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1002\/1873-3468.13680","volume":"593","author":"SY Sohn","year":"2019","unstructured":"Sohn SY, Hearing P (2019) Adenoviral strategies to overcome innate cellular responses to infection. FEBS Lett 593:3484\u20133495. https:\/\/doi.org\/10.1002\/1873-3468.13680","journal-title":"FEBS Lett"},{"issue":"2","key":"2567_CR39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000488846","volume":"9","author":"L Spadea","year":"2018","unstructured":"Spadea L, Tonti E, Spaterna A, Marchegiani A (2018) Use of ozone-based eye drops: a series of cases in veterinary and human spontaneous ocular pathologies. Case Rep Ophthalmol 9(2):287\u2013298. https:\/\/doi.org\/10.1159\/000488846","journal-title":"Case Rep Ophthalmol"},{"issue":"1","key":"2567_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jviromet.2008.06.004","volume":"153","author":"BK Murray","year":"2008","unstructured":"Murray BK, Ohmine S, Tomer DP, Jensen KJ, Johnson FB, Kirsi JJ, Robison RA, O\u2019Neill KL (2008) Virion disruption by ozone-mediated reactive oxygen species. J Virol Methods 153(1):74\u201377. https:\/\/doi.org\/10.1016\/j.jviromet.2008.06.004","journal-title":"J Virol Methods"},{"key":"2567_CR41","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1159\/000050884","volume":"215","author":"K Kashiwagi","year":"2001","unstructured":"Kashiwagi K, Saito K, Wang YD, Takahashi H, Ishijima K, Tsukahara S (2001) Safety of ozonated solution as an antiseptic of the ocular surface prior to ophthalmic surgery. Ophthalmologica 215:351\u2013356. https:\/\/doi.org\/10.1159\/000050884","journal-title":"Ophthalmologica"},{"issue":"12","key":"2567_CR42","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1007\/s10792-020-01503-4","volume":"40","author":"C Cagini","year":"2020","unstructured":"Cagini C, Mariniello M, Messina M, Muzi A, Balducci C, Moretti A, Levorato L, Menacci A (2020) The role of ozonized oil and a combination of tobramycin\/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial. Int Ophthalmol 40(12):3209\u20133215. https:\/\/doi.org\/10.1007\/s10792-020-01503-4","journal-title":"Int Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02567-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02567-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02567-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T15:06:08Z","timestamp":1682867168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02567-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2567"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02567-0","relation":{},"ISSN":["1573-2630"],"issn-type":[{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was compliant with the Declaration of Helsinki and additional approval was obtained from the Ethics Committee of Cukurova University, Medical Faculty, Adana, Turkey. (Number of meetings: 87; number of decisions: 9).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}